Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.74 EUR | +1.82% | +1.90% | -30.41% |
May. 31 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
May. 31 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
Trading Ideas
- Stock Market
- Equities
- GLPG Stock
- News Galapagos NV
- Trading Ideas